IGC Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 24 | BuyUS$200,000 | James Moran | Individual | 588,235 | US$0.34 |
Insider Trading Volume
Insider Buying: IGC insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 7,404,736 | 9.56% |
Institutions | 16,627,155 | 21.5% |
General Public | 53,417,483 | 69% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
13,823,529 | US$4.9m | -21.6% | no data | |||
4,353,417 | US$1.5m | 23.5% | no data | |||
1,042,917 | US$371.3k | -16.1% | no data | |||
1,037,000 | US$369.2k | 0% | no data | |||
942,402 | US$335.5k | 166% | no data | |||
703,798 | US$250.6k | 0% | no data | |||
645,166 | US$229.7k | 0% | no data | |||
562,969 | US$200.4k | 31% | no data | |||
165,307 | US$58.8k | 0% | no data | |||
123,060 | US$43.8k | 165% | no data | |||
116,401 | US$41.4k | 0% | no data | |||
103,443 | US$36.8k | 0% | 0.02% | |||
99,017 | US$35.3k | 195% | no data | |||
71,027 | US$25.3k | 0% | no data | |||
65,541 | US$23.3k | 0.07% | no data | |||
44,600 | US$15.9k | 28.9% | no data | |||
36,667 | US$13.1k | 0% | no data | |||
29,000 | US$10.3k | 0% | no data | |||
21,409 | US$7.6k | -3.2% | no data | |||
17,757 | US$6.3k | 1,960% | no data | |||
10,533 | US$3.7k | 0% | no data | |||
10,496 | US$3.7k | 30.9% | no data | |||
3,000 | US$1.1k | 0% | no data | |||
1,012 | US$361.2 | -49.7% | no data | |||
925 | US$328.1 | 15.6% | no data |